Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- CheckyesterdayChange DetectedA new NIH grant/contract reference was added to the study's identifier list, indicating funding attribution without changing the study’s design or participation criteria.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label on the page changed from v3.6.4 to v3.6.5, indicating a version update of the page template or site components. This reflects an internal update to the documentation or infrastructure rather than a modification to the study details or user-facing text.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects an updated release/version of the page documentation.SummaryDifference0.0%

- Check58 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing Revision: v3.6.0, indicating a newer site release without altering the study information.SummaryDifference0.0%

- Check72 days agoChange DetectedThe study page now shows recruitment status updates (Active, not recruiting; No longer looking for participants) and adds new guidance/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an estimated timeline and a page Revision: v3.6.0; older labels such as Completed and Actual were removed.SummaryDifference0.4%

- Check79 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor build update. This change does not modify the page content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.